Mens Health
Viagra
Cialis
Levitra
Propecia
Womens Health
Diflucan
Ortho Evra
Ortho Tricyclen
Plan B (Levonorgestrel)
Alesse
Seasonale
Yasmin
Sexual Health
Acyclovir
Aldara
Valtrex
Skin Care
Benzaclin
Retin A
Sleep Aids
Rozerem
Smoking Cessation
Chantix
Zyban
Weight Loss
Xenical
PainRelief
Butalbital
Tramadol
Ultracet
Ultram
Influenza
Amantadine
Relenza
Rimantadine
Tamiflu
Gastro-Intestinal
Nexium
 
News
 
Articles
 
Viagra might help in the Crohn's disease
SEPTEMBER 2006 OCTOBER 2006 NOVEMBER 2006 DECEMBER 2006

Researchers found evidence that suggests Crohn's disease is caused by a weak immune response.
The study, published in The Lancet, also suggest that Sildenafil ( Viagra ) might help in the treatment of the disease.

Crohn's disease is a chronic inflammatory disorder that causes ulcerations in the small and large intestines. Many researchers consider Crohn's to be an autoimmune disease -- an illness that occurs when the body tissues are attacked by its own immune system. However, Anthony Segal, at University College London, UK, and colleagues found that the inflammation in Crohn's arises due to a weak immune response.

The investigators looked at the quantities of neutrophils that patients with Crohn's disease produce in response to trauma at sites in the bowel and on the skin surface. They found that in response to trauma, Crohn's disease patients produced much lower quantities of neutrophils and inflammatory mediators when compared with healthy individuals. Cultured blood cells were also abnormal in the patients. To test the inflammatory response to bacteria, the team also measured local inflammatory and blood flow changes in participants after injecting a harmless form of Escherichia Coli under their skin. In the healthy controls, blood flow in the area of inflammation increased approximately ten-fold by 24 hours. Crohn's disease patients, however, had much lower blood flow than controls. The researchers found that the abnormally low blood flow in Crohn's patients could be corrected by treatment with Sildenafil, indicating a possible role for the drug in the treatment of the disease.

The authors believe that in Crohn's disease, reduced or delayed recruitment of neutrophils to sites at which bacteria penetrate the intestinal wall might lead to the persistence of bacteria and other organic debris in the tissue. The body may respond to this build up of bacteria by secreting inflammatory molecules, which accumulate and lead to the development of chronic inflammation typical of Crohn's.

Segal states: " Our investigations identified defective innate immunity in Crohn's disease. In Crohn's disease, a constitutionally weak immune response predisposes to accumulation of intestinal contents that breach the mucosal barrier of the bowel wall, resulting in granuloma formation and chronic inflammation."

Source: http://www.xagena.it/news/medicinenews_net_news/
fa7410de86471342fc198f32104ccb31.html


 
Home | SiteMap | Resources | Copyright©2006-2007 Benzer11.com All Rights Reserved. Privacy Policy
Benzer11.com is designed for educational and informational purpose. You cannot use this information as a substitute for the medical advice provided by your medical practitioner or other health care professional. We encourage you to read all the information of product. If you are suffering from any illness or disease or health problem, immediately contact your physician. Do not use the information mentioned in Benzer11.com for diagnosing or treating a medical problem or disease as results and side effects may vary among users.